Unlocking Value: Middle-Market Private Equity Opportunities in Theranostics (Part II)

Theranostics — melding precision diagnostics with targeted radiopharmaceutical therapy — has become a central focus in contemporary oncology. Middle-market investors are uniquely positioned to deploy capital into building the critical infrastructure that supports the theranostics supply chain and acquiring or licensing earlier-stage theranostic programs poised for growth….
By: McGuireWoods LLP